Clinical trial
Safety and Efficacy Study to Compare Two Rosacea Treatment Regimens
NCT00495313 · CollaGenex Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00495313 |
|---|---|
| Title | Safety and Efficacy Study to Compare Two Rosacea Treatment Regimens |
| Official title | Determine the Effects of COL-101 Administered Once Daily With Metronidazole Topical Gel, 1% Versus Doxycycline Hyclate 100 mg Administered Once Daily With Metronidazole Topical Gel, 1% in Patients With Moderate to Severe Rosacea |
| Lead sponsor | CollaGenex Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Rosacea |
| Intervention type | Drug |
| Interventions | doxycycline |
| Enrollment | 91 |
| Start date | Mar 1, 2007 |
| Primary completion | Dec 1, 2007 |
| Completion | Dec 1, 2007 |
| First posted | Jul 3, 2007 |
| Last update posted | Dec 16, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: